Macrophage activation comprises a continuum of functional states critically determined by
cytokine microenvironment. Activated macrophages have been functionally grouped according to their response to pro-Th1/proinflammatory stimuli [
lipopolysaccharide, IFNgamma,
granulocyte macrophage colony-stimulating factor (
GM-CSF); M1] or pro-Th2/anti-inflammatory stimuli [
interleukin (IL)-4,
IL-10,
M-CSF; M2]. We report that
folate receptor beta (FRbeta), encoded by the FOLR2 gene, is a marker for macrophages generated in the presence of
M-CSF (M2), but not
GM-CSF (M1), and whose expression correlates with increased
folate uptake ability. The acquisition of
folate uptake ability by macrophages is promoted by
M-CSF, maintained by
IL-4, prevented by
GM-CSF, and reduced by IFNgamma, indicating a link between FRbeta expression and M2 polarization. In agreement with in vitro data, FRbeta expression is detected in tumor-associated macrophages (TAM), which exhibit an M2-like functional profile and exert potent immunosuppressive functions within the
tumor environment. FRbeta is expressed, and mediates
folate uptake, by CD163(+) CD68(+) CD14(+) IL-10-producing TAM, and its expression is induced by
tumor-derived ascitic fluid and
conditioned medium from fibroblasts and tumor cell lines in an
M-CSF-dependent manner. These results establish FRbeta as a marker for M2 regulatory macrophage polarization and indicate that
folate conjugates of therapeutic drugs are a potential
immunotherapy tool to target TAM.